Ishimi Y, Ishida R, Andoh T
Mitsubishi Kasei Institute of Life Sciences, Tokyo, Japan.
J Mol Biol. 1995 Apr 14;247(5):835-9. doi: 10.1006/jmbi.1995.0183.
The effect of ICRF-193, a non-cleavable, complex-stabilizing type of topoisomerase II inhibitor, on SV40 DNA replication in vivo was examined. As analyzed by one and two-dimensional gel electrophoresis, C-family catenated dimers, each composed of two intertwined, covalently closed SV40 DNAs, were mainly synthesized in the presence of the drug. On removal of the drug these C-family dimers were segregated into monomers. These results indicate that topoisomerase II is required for the segregation of replicated daughter molecules, but it is not absolutely required for the replication of DNA molecules up to the C-family dimers.
研究了一种不可切割、稳定复合物型拓扑异构酶II抑制剂ICRF-193对SV40 DNA体内复制的影响。通过一维和二维凝胶电泳分析,发现主要在药物存在的情况下合成了C家族连环二聚体,每个二聚体由两个相互缠绕、共价闭合的SV40 DNA组成。去除药物后,这些C家族二聚体分离为单体。这些结果表明,拓扑异构酶II对于复制后的子代分子的分离是必需的,但对于DNA分子复制至C家族二聚体并非绝对必需。